Spire Wealth Management Oragenics Inc Transaction History

Spire Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$0.11 - $15.59 $24 - $3,445	-221 Reduced 3.2%	6,688 $1,000
Q3 2022 Nov 07, 2022	SELL	$0.23 - $14.18 $5 - $326	-23 Reduced 0.33%	6,909 $2,000
Q2 2022 Jul 22, 2022	SELL	$0.24 - $0.42 $16 - $28	-68 Reduced 0.97%	6,932 $2,000
Q1 2022 Apr 18, 2022	SELL	$0.33 - $0.56 $2,640 - $4,480	-8,000 Reduced 53.33%	7,000 $2,000
Q4 2021 Jan 14, 2022	BUY	$0.43 - $0.69 $1,290 - $2,070	3,000 Added 25.0%	15,000 $7,000
Q2 2021 Jul 26, 2021	SELL	$0.6 - $0.89 $3,000 - $4,450	-5,000 Reduced 29.41%	12,000 $8,000
Q1 2021 May 21, 2021	BUY	$0.52 - $1.52 $8,840 - $25,840	17,000 New	17,000 $15,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $40.7M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.